Description:
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide studied for its potential roles in sleep regulation, stress response, and neuroprotection. While its exact mechanisms remain under investigation, DSIP continues to be a subject of interest in neuroendocrine research. Dosing Protocol (SubQ or Intranasal):
Research Application:
Suggested Dose: 100–200 mcg per administration
Some protocols report titrating up to 400 mcg based on individual tolerance and response.
Frequency:
Typically administered once daily, 30–60 minutes before bedtime for sleep-related protocols.
May also be used during the day in studies focused on stress or anxiety.
Duration:
Short-term use (1–2 weeks) is common, though longer research cycles (4–6 weeks or more) may be employed based on experimental goals.
Availability:
Purity: ≥99%
Form: Lyophilized powder for reconstitution
Disclaimer:
The statements made on this website have not been evaluated by the US Food and Drug Administration. These are not findings from Raina's Summit, but instead publicly available studies. This product is for research purposes only.
DSIP (5mg - 10mg)
C35H48N10O15
At Raina's Summit, we are committed to providing research compounds of the highest standard—we perform quality batch testing to verify each product meets a minimum purity of 99% or we guarantee your money back.